Document:

Accelerated Share Repurchase Transaction at Discount to VWAP

 EXHIBIT 10.28 
  

					
	Reference Number CCEGK5-1/	 	Account Number: 3315851	 	 

  

			
	

	  	 MORGAN STANLEY & CO. INCORPORATED
 1585 BROADWAY
 NEW YORK, NY 10036-8293
 (212) 761-4000

  
 November 21, 2005

  
 Accelerated Share Repurchase Transaction at Discount to VWAP

  
 VERISIGN, INC. 
 487 East Middlefield Road 
 Mountain View, CA 94043 
  

  
 Dear
Sir/Madam: 
  
 The purpose of this letter agreement (this
“Confirmation”) is to confirm the terms and conditions of the Transaction entered into between Morgan Stanley & Co. Incorporated (“MSCO”) and VERISIGN, INC. (the “Issuer”) on the Trade Date specified below (the
“Transaction”). This confirmation constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. 
  
 The definitions and provisions contained in the 2002 ISDA Equity Derivatives Definitions (as published by the International Swaps and Derivatives Association, Inc.
(“ISDA”)) (the “Equity Definitions”) are incorporated into this Confirmation. In the event of any inconsistency between the Equity Definitions and this Confirmation, this Confirmation will govern. Any reference to a currency
shall have the meaning contained in Annex A to the 1998 ISDA FX and Currency Option Definitions, as published by ISDA. 
  
 1. All provisions contained in or incorporated by reference in the form of the 1992 ISDA Master Agreement (Multicurrency-Cross Border) (the “ISDA Form” or the
“Agreement”), will govern this Master Confirmation and each Supplemental Confirmation except as expressly modified below. This Confirmation and each Supplemental Confirmation, together with all other documents referring to the Agreement
confirming Transactions entered into between MSCO and Counterparty shall supplement, form a part of, and be subject to the ISDA Form as if MSCO and Counterparty had executed the Agreement (but without any Schedule except for (i) the election of
Loss and Second Method, New York law (without regard to the conflicts of law principles) as the governing law and US Dollars (“USD”) as the Termination Currency and (ii) the election that subparagraph (ii) of Section 2(c)
will not apply to Transactions, 
  
 2. The terms of the particular Transaction to
which this Confirmation relates are as follows: 
  
 GENERAL TERMS:

  

	 Trade Date: 
	 As specified in Schedule I 

  

	 Buyer: 
	 Issuer 

  

	 Seller: 
	 MSCO 

  

	 Shares: 
	 Common Stock of Issuer (Ticker: VRSN) 

					
	Reference Number CCEGK5-1/	 	Account Number: 3315851	 	 Page
 2

  

	 Number of Shares: 
	 The number of Shares delivered in accordance with Physical Settlement below 

  

	 Forward Price: 
	 A price per Share (as determined by the Calculation Agent equal to (i) the sum of the 10b-18 VWAP for each Trading Day during the Calculation
Period divided by (ii) the number of Trading Days in the Calculation Period minus (iii) the Discount Percentage (as specified in Schedule I) multiplied by the Initial Hedge Period Reference Price; provided, however, that in
no case shall the Forward Price be greater than the Maximum Forward Price (as specified in Schedule I). 

  

	 10b-18 VWAP: 
	 For each Trading Day during the Calculation Period, a price per share (as determined by the Calculation Agent) equal to the volume-weighted
average price of the Rule 10b-18 eligible trades in the Shares for the entirety of such Trading Day as determined by reference to the screen entitled “VRSN.Q EQUITY AQR SEC” as reported by Bloomberg L.P. (without regard to pre-open or
after hours trading outside of any regular trading session for such Trading Day) 

  

	 Calculation Period: 
	 The period from and including the first Trading Day that occurs after the Initial Hedge Completion Date to and including the Valuation Date.

  

	 Trading Day: 
	 Any Exchange Business Day that is not a Disrupted Day 

  

	 Initial Hedge Period: 
	 The period from and including the Trade Date to and including the Initial Hedge Completion Date 

  

	 Initial Hedge Completion Date: 
	 The date on which MSCO completes its initial hedge, as determined by MSCO in its sole discretion 

  

	 Initial Hedge Period Reference Price: 
	 A price per share (as determined by the Calculation Agent) equal to the average price at which MSCO purchases the Shares constituting its initial
hedge 

  

	 Initial Shares: 
	 The Prepayment Amount divided by the Initial Hedge Period Reference Price 

  

	 Initial Share Delivery Date: 
	 One Exchange Business Day after the Initial Hedge Completion Date. On the Initial Share Delivery Date, Seller shall deliver a number of shares
equal to the Initial Shares to Buyer in accordance with Section 9.4 of the Equity Definitions, with the Initial Share Delivery Date deemed to be a “Settlement Date” for purposes of such Section 9.4. 

 

	 Prepayment: 
	 Applicable 

  

	 Prepayment Amount: 
	 As specified in Schedule I 

  

	 Prepayment Date: 
	 One Exchange Business Day after the Initial Hedge Completion Date 

					
	Reference Number CCEGK5-1/	 	Account Number: 3315851	 	 Page
 3

  

	 Exchange: 
	 The NASDAQ National Market 

  

	 Related Exchange: 
	 The primary exchange on which options or futures on the relevant Shares are traded. 

  

	 Market Disruption Event: 
	 The definition of “Market Disruption Event” in Section 6.3(a) of the Equity Definitions is hereby amended by inserting the words
“at any time on any Scheduled Trading Day during the Calculation Period or” after the word “material,” in the third line thereof. 

  

	 	 Notwithstanding anything to the contrary in the Equity Definitions, if any Scheduled Trading Day in the Calculation Period is a Disrupted Day, the
Calculation Agent shall have the option in its sole discretion either (i) to determine the weighting of each Rule 10b-18 eligible transaction in the Shares on the relevant Disrupted Day using its commercially reasonable judgment for purposes of
calculating the Forward Price, as applicable, (ii) to elect to extend the Calculation Period by a number of Scheduled Trading Days equal to the number of Disrupted Days during the Calculation Period or (iii) to suspend the Calculation
Period, as appropriate, until the circumstances giving rise to such suspension have ceased. 

  
 VALUATION: 
  

	 Valuation Time: 
	 The Scheduled Closing Time on the relevant Exchange 

  

	 Valuation Date: 
	 The earlier of (i) the Scheduled Valuation Date (as specified in Schedule I) and (ii) the date specified by MSCO to Issuer as the
Valuation Date, subject to extension in accordance with “Market Disruption Event” above or Section 7 or Section 9 below. On the Valuation Date, Calculation Agent shall calculate the Settlement Amount.

  

	 Settlement Amount: 
	 The Prepayment Amount minus the Forward Amount 

  

	 Forward Amount: 
	 The Forward Price multiplied by the Initial Shares 

  
 SETTLEMENT TERMS: 
  

	 Physical Settlement: 
	 Applicable. On the Settlement Date, if the Settlement Amount (as defined above) is greater than zero, then Seller shall make a cash payment to
Buyer in an amount equal to the Settlement Amount; provided, however, that Buyer may deliver to Seller a notice by no later than 4:00p.m. on the Exchange Business Day immediately preceding the Settlement Date electing for Seller to deliver the
requisite number of Refund Shares (as defined below) in lieu of 

					
	Reference Number CCEGK5-1/	 	Account Number: 3315851	 	 Page
 4

  

	 	 payment of the Settlement Amount. The delivery of any Refund Shares shall be effected in accordance with “Delivery of Refund Shares”
below. 

  

	 	 On the Settlement Date, if the Settlement Amount is less than zero, then Buyer shall make a cash payment to Seller in an amount equal to the
absolute value of the Settlement Amount; provided, however, that Buyer may deliver to Seller a notice by no later than 4:00p.m. on the Exchange Business Day immediately preceding the Settlement Date electing to deliver the requisite number of
Payment Shares (as defined below) in lieu of payment of the Settlement Amount. The delivery of any Refund Shares shall be effected in accordance with “Delivery of Payment Shares” below. 

  

	 	 If Seller suspends the Calculation Period, the suspension shall be treated as a Potential Adjustment Event subject to Calculation Agent
Adjustment. In the case of a suspension pursuant to Section 9, the Calculation Agent shall make such adjustments prior to the period of suspension, if it is practical to do so. Otherwise, and in all cases of a suspension as contemplated under
“Market Disruption Event” above, the Calculation Agent shall make such adjustments promptly following the period of suspension. 

  

	 Settlement Currency: 
	 USD 

  

	 Settlement Date: 
	 Three Exchange Business Days after the Valuation Date, or if such date is not a Clearance System Business Day or if there is a Settlement
Disruption Event on such day, the immediately succeeding Clearance System Business Day on which there is no Settlement Disruption Event. 

  
 PROCEDURE FOR DELIVERY OF SHARES: 
  

	 Delivery of Refund Shares: 
	 If Buyer elects for Seller to satisfy its payment obligation of the Settlement Amount by delivering Refund Shares, then on the Valuation Date, a
Settlement Balance shall be established with an initial balance equal to the Settlement Amount. On a Trading Day after the Settlement Date chosen by Seller, Seller shall commence purchasing Shares for delivery to Issuer (such Shares, “Refund
Shares”) which transactions shall be in compliance with Rule 10b-18 under the Exchange Act. At the end of each Trading Day on which Seller purchases Refund Shares, Seller shall reduce the Settlement Balance by the aggregate market value of the
Shares purchased on such Trading Day. Seller shall deliver the Refund Shares for each Trading day to Buyer on the third Exchange Business Day after the relevant Trading Day. Seller shall continue 

					
	Reference Number CCEGK5-1/	 	 Account Number: 3315851
  
	 	 Page
 5

	 	 purchasing Refund Shares (in compliance with Rule 10b-18 under the Exchange Act) until the Settlement Balance has been reduced to zero.

  

	 Delivery of Payment Shares 
	 If Buyer elects to satisfy its payment obligation of the Settlement Amount by delivering Payment Shares, then on the Valuation Date a Settlement
Balance shall be created with an initial balance equal to the absolute value of the Settlement Amount. On the Settlement Date, Buyer shall deliver to Seller a number of shares (such shares, “Payment Shares”) rounded up to the nearest whole
number equal to the absolute value of the Settlement Balance divided by the Private Placement Value (as defined below). Following the delivery of Payment Shares or any Make-Whole Payment Shares (as defined below), Seller shall sell all such
Payment Shares or Make-Whole Payment Shares in a commercially reasonable manner. At the end of each Trading Day upon which sales have been made, the Settlement Balance shall be reduced by an amount equal to the aggregate proceeds received by
Seller upon the sale of such Payment Shares or Make-Whole Payment Shares. If, on any Trading Day, all Payment Shares and Make-Whole Payment Shares have been sold and the Settlement Balance has not been reduced to zero, the Company shall
(i) deliver to Seller or as directed by Seller on the third Exchange Business Day after such Trading Day an additional number of Shares (the “Make-Whole Payment Shares”, which once delivered, shall be considered to be Payment
Shares) equal to (x) the Settlement Balance as of such Trading Day divided by (y) the Private Placement Value or (ii) promptly deliver to Seller cash in an amount equal to the then remaining Settlement Balance. This provision
shall be applied successively until either the Settlement Balance is reduced to zero or the aggregate number of Payment Shares and Make-Whole Payment Shares equals the Share Cap (as defined below). Seller can only elect to deliver Payment Shares or
Make-Whole Payment Shares if the Conditions to Delivery of Payment Shares are met on each day during the period from and including the Valuation Date to and including the date upon which the relevant Settlement Balance is reduced to zero. If the
Settlement Balance is zero and not all the Payment Shares or Make-Whole Payment Shares have been sold to satisfy the Settlement Balance, then Seller shall promptly return the remaining the Payment Shares and/or Make-Whole Payment Shares to Buyer.

  

	 Share Adjustments: 
	

  

	 Method of Adjustment: 
	 Calculation Agent Adjustment 

					
	Reference Number CCEGK5-1/	 	Account Number: 3315851	 	 Page
 6

  

 EXTRAORDINARY EVENTS: 
  

Consequences of Merger Events: 
  

	 Share-for-Share: 
	 Modified Calculation Agent Adjustment 

  

	 Share-for-Other: 
	 Cancellation and Payment on that portion of the other Consideration that consists of cash; Modified Calculation Agent Adjustment on the remainder
of the Other Consideration 

  

	 Share-for-Combined: 
	 Component Adjustment 

  

	 Determining Party: 
	 Calculation Agent 

  

	 Tender Offer: 
	 Applicable 

  
 Consequences of Tender Offers: 
  

	 Share-for-Share: 
	 Modified Calculation Agent Adjustment 

  

	 Share-for-Other: 
	 Cancellation and Payment on that portion of the other Consideration that consists of cash; Modified Calculation Agent Adjustment on the remainder
of the Other Consideration 

  

	 Share-for-Combined: 
	 Component Adjustment 

  

	 Determining Party: 
	 Calculation Agent 

  
 For purposes of this Transaction, the definition of Merger Date in Section 12.1(c) shall be amended to read, “Merger Date shall mean the Announcement
Date.” For purposes of this Transaction, the definition of Tender Offer Date in Section 12.1(e) shall be amended to read, “Tender Offer Date shall mean the Announcement Date.” 
  

	 Composition of Combined Consideration: 
	 Applicable 

  

	 Nationalization, Insolvency or Delisting: 
	 Cancellation and Payment 

  

	 Determining Party: 
	 Calculation Agent 

  
 Additional Disruption Events: 
  

	 Change in Law: 
	 Applicable 

  

	 Failure to Deliver: 
	 Applicable 

  

	 Insolvency Filing: 
	 Applicable 

  

	 Hedging Disruption: 
	 Applicable 

  

	 Hedging Party: 
	 Seller 

  

	 Increased Cost of Hedging: 
	 Applicable 

  

	 Hedging Party: 
	 Seller 

  

	 Loss of Stock Borrow: 
	 Applicable 

					
	Reference Number CCEGK5-1/	 	Account Number: 3315851	 	 Page
 7

  

 Maximum Stock Loan Rate: 
  

	 Increased Cost of Stock Borrow: 
	 Applicable 

  
 Initial Stock Loan Rate: 
  

	 Determining Party: 
	 Seller 

  

	 Non-Reliance: 
	 Applicable 

  
 AGREEMENTS AND ACKNOWLEDGMENTS: 
  

	 Regarding Hedging Activities: 
	 Applicable 

  

	 Additional Acknowledgments: 
	 Applicable 

  

	 3. Calculation Agent: 
	 The Calculation Agent identified in the Agreement. 

  

	 4. Account Details: 
	 To be provided. 

  
 5.       (a) Nationalization or Insolvency. The words “the Transaction will be cancelled,” in the first line of
Section 12.6(c)(ii) are replaced with the words “MSCO will have the right to cancel this Transaction,”. 
  
 (b) Additional Termination Event. Any cash dividend declared by the issuer that exceeds the Ordinary Cash Dividend shall constitute an Additional
Termination Event with this Transaction as the only “Affected Transaction” and MSCO as the sole Affected Party. “Ordinary Cash Dividend” shall mean $0.00 per Share. 
  
 (c) For the avoidance of doubt, this Transaction shall be deemed to be a “Forward Transaction for purposes of the
Equity Definitions. 
  
 6. Conditions to Delivery of Payment Shares. 

 
 (a) Issuer may only deliver Payment Shares and Make-Whole
Payment Shares subject to satisfaction of the following conditions: 
  
 (i) all Payment Shares and Make-Whole Payment Shares shall be delivered to the Seller (or any affiliate of the Seller designated by the Seller) pursuant to the exemption from the registration requirements of the
Securities Act provided by Section 4(2) thereof; 
  
 (ii) Seller and any potential purchaser of any such shares from the Seller (or any affiliate of the Seller designated by the Seller) identified by Seller shall have been afforded a commercially reasonable opportunity
to conduct a due diligence investigation with respect to Issuer customary in scope for private placements of equity securities (including, without limitation, the right to have made available to them for inspection all financial and other records,
pertinent corporate documents and other information reasonably requested by them) and Buyer shall not disclose material non-public information in connection with such due diligence investigation; and 
  
 (iii) an agreement (a “Private Placement
Agreement”) shall have been entered into between Issuer and the Seller (or any affiliate of the Seller designated by the Seller) in connection with the private placement of such shares by Issuer to the Seller (or any such affiliate) and the
private resale of such shares by the Seller (or any such affiliate), substantially similar to private placement purchase agreements customary for private placements of equity securities, in form and substance commercially reasonably satisfactory to
the Seller and the Issuer, which Private Placement Agreement shall include, without limitation, provisions substantially similar to those contained in such private placement purchase agreements relating to the indemnification of, and contribution in
connection with the 

					
	Reference Number CCEGK5-1/	 	Account Number: 3315851	 	 Page
 8

  

 
liability of, the Seller and its affiliates, and shall provide for the payment by Issuer of all fees and expenses in connection with such resale, including
all reasonable fees and expenses of one counsel for the Seller but not including any underwriter or broker discounts and commissions, and shall contain representations, warranties and agreements of Issuer and Seller reasonably necessary or advisable
to establish and maintain the availability of an exemption from the registration requirements of the Securities Act for such resales. 
  
 (b) If Issuer elects to deliver Payment Shares to satisfy its payment obligation of the Settlement Amount, neither Issuer nor Seller shall take or cause
to be taken any action that would make unavailable either (i) the exemption set forth in Section 4(2) of the Securities Act for the sale of any Payment Shares or Make-Whole Payment Shares by Issuer to the Seller or (ii) an
exemption from the registration requirements of the Securities Act reasonably acceptable to the Seller for resales of Payment Shares and Make-Whole Payment Shares by the Seller. 
  
 (c) If the Settlement Amount is less than zero and Issuer elects to deliver Payment Shares to satisfy its payment obligation
of the Settlement Amount, then, if necessary, Issuer shall use its best efforts to cause the number of authorized but unissued shares of Common Stock to be increased to an amount sufficient to permit Issuer to fulfill its obligations “Delivery
of Payment Shares” above. 
  
 7. Certain Payments and Deliveries by MSCO.
Notwithstanding anything to the contrary herein, or in the Equity Definitions, if at any time (i) an Early Termination Date occurs and MSCO would be required to make a payment pursuant to Sections 6(d) and 6(e) of the Agreement, (ii) a
Tender Offer occurs and MSCO would be required to make a payment pursuant to Sections 12.3 and 12.7 of the Equity Definitions, (iii) a Merger Event occurs and MSCO would be required to make a payment pursuant to Sections 12.2 and 12.7 of the
Equity Definitions or (iv) an Additional Disruption Event occurs and MSCO would be required to make a payment pursuant to Sections 12.8 and 12.9 of the Equity Definitions, then in lieu of such payment, MSCO shall deliver to Issuer, at the time
such payment would have been due and in the manner provided under “Physical Settlement” in the Equity Definitions, a number of Shares (or, in the case of a Merger Event, common equity securities of the surviving entity) equal to the
quotient obtained by dividing (A) the amount that would have been so payable by (B) the fair market value per Share (or per unit of such common equity security) of the Shares (or units) so delivered at the time of such delivery, as
determined by the Calculation Agent in a commercially reasonable manner. The Calculation Agent hereby agrees to provide the parties with a statement of its calculation hereunder. 
  
 8. Certain Payments and Deliveries by Issuer. Notwithstanding anything to the contrary herein, or in the Equity Definitions, if at any time
(i) an Early Termination Date occurs and Issuer would be required to make a payment pursuant to Sections 6(d) and 6(e) of the Agreement, (ii) a Tender Offer occurs and Issuer would be required to make a payment pursuant to Sections 12.3
and 12.7 of the Equity Definitions, (iii) a Merger Event occurs and Issuer would be required to make a payment pursuant to Sections 12.2 and 12.7 of the Equity Definitions or (iv) an Additional Disruption Event occurs and Issuer would be
required to make a payment pursuant to Sections 12.8 and 12.9 of the Equity Definitions (any such payment described in Sections 8(i), (ii), (iii), or (iv) above, an “Early Settlement Payment”), then Issuer shall have the option, in
lieu of making such cash payment, to settle its payment obligations under Sections 8(i), (ii), (iii), or (iv) above in Shares (such Shares, the “Early Settlement Shares”). The provisions of “Delivery of Payment Shares”
in Section 2 above shall apply to the delivery of Early Settlement Shares as if the relevant Early Settlement Amount was the “Settlement Amount” and the Early Settlement Shares were “Payment Shares”, In order to elect to
deliver Early Settlement Shares, (i) Issuer must notify MSCO of its election by no later than 4 p.m. on the date that is three Exchange Business Days before the date that the Early Settlement Payment is due and (ii) the conditions
described in Section 6 above must be satisfied as if the Early Settlement Shares were “Payment Shares” and 

					
	Reference Number CCEGK5-1/	 	Account Number: 3315851	 	 Page
 9

  

 
any additional Shares Issuer delivers to reduce the settlement balance to zero in connection with this Section 8 were “Make-Whole Payment
Shares”. 
  
 9. Special Provisions for Merger Events. Notwithstanding
anything to the contrary herein or in the Equity Definitions, to the extent that an Announcement Date for a potential Merger Transaction occurs during the term of this Transaction: 
  
 (a) As soon as practicable following the public announcement of such potential Merger Transaction, Issuer shall provide MSCO
with written notice of such announcement; 
  
 (b) Promptly after
request from MSCO, Issuer shall provide MSCO with written notice specifying (i) Issuer’s average daily Rule 10b-18 Purchases (as defined in Rule 10b-18) during the three full calendar months immediately preceding the Announcement Date that
were not effected through MSCO or its affiliates and (ii) the number of Shares purchased pursuant to the proviso in Rule 10b-18(b)(4) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) for the three full
calendar months preceding the Announcement Date. Such written notice shall be deemed to be a certification by Issuer to MSCO that such information is true and correct. Issuer understands that MSCO will use this information in calculating the trading
volume for purposes of Rule 10b-18; and 
  
 (c) MSCO in its
sole discretion may extend the Calculation Period to account for any reduction in the number of Shares that could be purchased on each day during the Calculation Period in compliance with Rule 10b-18 following the Announcement Date. 
  
 “Merger Transaction” means any merger, acquisition or similar
transaction involving a recapitalization of Issuer as contemplated by Rule 10b-18(a)(13)(iv) under the Exchange Act. 
  
 10. Seller Adjustments. In the event that Seller reasonably determines that it is appropriate with regard to any legal, regulatory or self-regulatory requirements or
related policies and procedures (whether or not such requirements, policies or procedures are imposed by law or have been voluntarily adopted by Seller, and including, without limitation, Rule 10b-18, Rule 10b-5, Regulation 13D-G and Regulation 14E,
“Requirements”), for Seller to refrain from purchasing Shares or to purchase fewer than the number of Shares Seller would otherwise purchase on any Trading Day during the duration of this Transaction, then Seller may, in its discretion,
elect that the Initial Hedge Period or the Calculation Period, as the case may be, be suspended and, if appropriate, extended with regard to any Requirements. Seller shall notify the Issuer upon the exercise of Seller’s rights pursuant to this
Section 10 and shall subsequently notify the Issuer on the day Seller believes that the circumstances giving rise to such exercise have changed. If the Initial Hedge Period or the Calculation Period is suspended pursuant to this
Section 10, at the end of such suspension Seller shall determine the number of Trading Days remaining in the Calculation Period, as appropriate, and the terms of this Transaction shall be adjusted as set forth above under “Physical
Settlement.” 

					
	Reference Number CCEGK5-1/	 	Account Number: 3315851	 	 Page
 10

  

	11.	Covenants. 

  
 The Buyer covenants and agrees: 
  
 (i)(a) that it will not treat this Transaction, any portion hereof, or any obligation hereunder as giving rise to any interest income or other inclusions of ordinary income; (b) it will not treat the delivery of any portion of the
Shares or cash to be delivered pursuant to this Transaction as the payment of interest or ordinary income; (c) it will treat this Transaction in its entirety as a forward contract for the delivery of such Shares or cash; and (d) it will
not take any action (including filing any tax return or form or taking any position in any tax proceeding) that is inconsistent with the obligations contained in (a) through (c). Notwithstanding the preceding sentence, Buyer may take any action
or position required by law, provided that Buyer delivers to Seller an opinion of counsel, nationally recognized as expert in Federal tax matters and acceptable to Buyer, to that effect; 
  
 (ii) that during the term of this Agreement, neither it nor any of its affiliates shall directly or indirectly (which shall
be deemed to include the writing or purchase of any cash-settled derivative instrument) purchase Shares (or any security convertible into or exchangeable for Shares) without the prior written approval of Seller or take any other action that would
cause the purchase by Seller of any Shares in connection with this Agreement not to comply with Rule 10b-18 under the Exchange Act (assuming for the purposes of this paragraph that such Rule were otherwise applicable to such purchases); 

 
 (iii) to comply with all laws, rules and regulations applicable to it
(including, without limitation, the Securities Act of 1933, as amended (the “Securities Act”) and the Exchange Act) in connection with the transactions contemplated by this Confirmation; and 
  
 (iv) that it is not relying, and has not relied, upon Seller or any of its
representatives or advisors with respect to the legal, accounting, tax or other implications of this Agreement and that it has conducted its own analyses of the legal, accounting, tax and other implications of this Agreement. Buyer understands and
acknowledges that Seller and its affiliates may from time to time effect transactions for their own account or the account of customers and hold positions in securities or options on securities of the Buyer and that Seller and its affiliates may
continue to conduct such transactions during the term of this Agreement. 
  
 (v) that neither it nor any affiliates shall take any action that would cause Regulation M under the Securities Exchange Act of 1934, as amended (“Regulation M”), to be applicable to any purchases of Shares,
or any security for which Shares is a reference security (as defined in Regulation M), by Buyer or any affiliated purchasers (as defined in Regulation M) during the Calculation Period. 
  
 Seller covenants and agrees that with respect to the purchase of any Shares in connection with this Agreement (except for any purchases made
by Seller during the Calculation Period in connection with dynamic hedge adjustments of the Seller’s exposure to the Transaction as a result of any equity optionality contained in such Transaction (including adjustments made in connection with
Seller’s right to specify the Final Valuation Date as described under “Final Valuation Date” above)), Seller shall make any such purchase in a manner that Seller reasonably believes, based on the representations and warranties set
forth herein and any other information provided to Seller by Buyer, would meet the requirements of the safe harbor under the provisions of Rule 10b-18, including without limitation the “one-broker rule” under Rule 10b-18(b)(1) under the
Exchange Act, as if such purchases were made by Buyer; provided, however, that it is understood and agreed that Seller will not be obligated to comply with this paragraph if an Extraordinary Event occurs. 
  
 12. Representations, Warranties and Acknowledgments. 
  
 The Buyer hereby represents and warrants to Seller that: 
  
 (i) as of the date hereof, the Buyer (A) is not in possession of any
material, non-public information with respect to the Buyer or any of its securities, and is entering into this Agreement in good faith 

					
	Reference Number CCEGK5-1/	 	Account Number: 3315851	 	 Page
 11

  

 
and not as part of a plan or scheme to evade the prohibitions of Rule 10b5-1 of the Exchange Act and (B) agrees not to alter or deviate from the terms
of this Agreement or enter into or alter a corresponding or hedging transaction or position with respect to the Shares (including, without limitation, with respect to any securities convertible or exchangeable into the Shares) during the term of
this Agreement; 
  
 (ii) the transactions contemplated by this
Confirmation have been authorized under Buyer’s publicly announced program to repurchase Shares; 
  
 (iii) the Buyer is not entering into this Agreement to facilitate a distribution of the Shares (or any security convertible into or exchangeable for
Shares) or in connection with a future issuance of securities except pursuant to the Buyer’s employee benefit plans and dividend reinvestment plan or other publicly disclosed transaction; 
  
 (iv) the Buyer is not entering into this Agreement to create actual or
apparent trading activity in the Shares (or any security convertible into or exchangeable for Shares) or to raise or depress the price of the Shares (or any security convertible into or exchangeable for Shares); and 
  
 (v) the Buyer is as of the date hereof, and after giving effect to the
transactions contemplated hereby will be, Solvent. As used in this paragraph, the term “Solvent” means, with respect to a particular date, that on such date (A) the present fair market value (or present fair saleable value) of the
assets of the Buyer is not less than the total amount required to pay the liabilities of the Buyer on its total existing debts and liabilities (including contingent liabilities) as they become absolute and matured, (B) the Buyer is able to
realize upon its assets and pay its debts and other liabilities, contingent obligations and commitments as they mature and become due in the normal course of business, (C) assuming consummation of the transactions as contemplated by this
Agreement, the Buyer is not incurring debts or liabilities beyond its ability to pay as such debts and liabilities mature, (D) the Buyer is not engaged in any business or transaction, and does not propose to engage in any business or
transaction, for which its property would constitute unreasonably small capital after giving due consideration to the prevailing practice in the industry in which the Buyer is engaged and (E) the Buyer is not a defendant in any civil action
that could reasonably be expected to result in a judgment that the Company is or would become unable to satisfy. 
  
 Seller and the Buyer each hereby acknowledges that any transactions by Seller in the Shares will be undertaken by Seller, as the case may be, as principal for its own
account. All of the actions to be taken by Seller in connection with this Agreement, shall be taken by Seller independently and without any advance or subsequent consultation with the Buyer. 
  
 13. Acknowledgements of Buyer Regarding Hedging and Market Activity. 
  
 Buyer agrees, understands and acknowledges that: 
  
 (i) during the period from (and including) the Trade Date to
(and including) the Settlement Date, Seller and its affiliates may buy or sell Shares or other securities or buy or sell options or futures contracts or enter into swaps or other derivative securities in order to adjust its hedge position with
respect to the transactions contemplated by this Transaction;
  
 (ii) Seller and its affiliates also may be active in the market for the Shares other than in connection with hedging activities in relation to the transactions contemplated by this Transaction;
  
 (iii) Seller shall make its own determination as to whether,
when or in what manner any hedging or market activities in the Issuer’s securities shall be conducted and shall do so 

					
	Reference Number CCEGK5-1/	 	Account Number: 3315851	 	 Page
 12

  

 
in a manner that it deems appropriate to hedge its price and market risk with respect to 10b-18 VWAP; and 
  
 (iv) any market activities of Seller and its affiliates with
respect to the Shares may affect the market price and volatility of the Shares, as well as the 10b-18 VWAP, each in a manner that may be adverse to Buyer. 
  
 14. Indemnification. 
  
 (a) In the event that Seller becomes involved in any capacity in any action, proceeding or investigation brought by or against any person in connection
with any matter referred to in this Agreement, the Buyer will reimburse Seller for its reasonable legal and other expenses (including the cost of any investigation and preparation) incurred in connection therewith. The Buyer also will indemnify and
hold Seller harmless against any losses, claims, damages or liabilities to which it may become subject in connection with any matter referred to in this Agreement, except to the extent that any such loss, claim, damage or liability results from
(i) the gross negligence or bad faith of Seller in effecting the transactions which are the subject of this Agreement; (ii) Seller’s breach of any covenant under this Agreement; or (iii) the purchase of any Shares in connection
with this Agreement unless the loss, claim, damage or liability in connection therewith results from Buyer’s breach of this Agreement; provided, however, that if it is determined by a court of competent jurisdiction in a final judgment
that Seller is not entitled to be indemnified hereunder in connection with such matter, then Seller shall reimburse the Buyer for any expenses paid pursuant to the first sentence of this Section 14. If for any reason the foregoing
indemnification is unavailable to Seller or insufficient to hold it harmless, then the Buyer shall contribute to the amount paid or payable by Seller as a result of such loss, claim, damage or liability in such proportion as is appropriate to
reflect the relative fault of the Buyer on one hand and Seller on the other hand with respect to such loss, claim, damage, or liability and any other relevant equitable considerations. The reimbursement, indemnity and contribution obligations of the
Buyer under this Section 14 shall be in addition to any liability which the Buyer may otherwise have, shall extend upon the same terms and conditions to any affiliate of Seller and the partners, directors, officers, agents, employees and
controlling persons (if any), as the case may be, of Seller and any such affiliate and shall be binding upon and inure to the benefit of any successors, assigns, heirs and personal representatives of the Buyer, Seller, any such affiliate and any
such person. The Buyer also agrees that neither Seller nor any of such affiliates, partners, directors, officers, agents, employees or controlling persons shall have any liability to the Buyer for or in connection with any matter referred to in this
Agreement except to the extent that any losses, claims, damages, liabilities or expenses incurred by the Buyer result from the gross negligence or bad faith of Seller in effecting the transactions that are the subject of this Agreement. The
foregoing provisions shall survive any termination or completion of this Agreement. For the purposes of this Section 14, the term “Seller” shall include Morgan Stanley and its affiliates. 
  
 (b) Subject to Section 14(c), the reimbursement, indemnity and
contribution obligations of the Buyer under Section 14(a) (each, an “Obligation”) shall be paid in cash. 
  
 (c) (i) In connection with any Obligation, the Buyer may elect to satisfy such Obligation by delivering Shares to Seller (a “Net Share
Settlement”) by notifying Seller of such election within one Trading Day of being informed by Seller that such Obligation is due and payable. 
  
 (ii) If Net Share Settlement is timely elected by the Buyer, then the Buyer shall deliver to Seller a number of validly issued Shares as determined below
in Section 14(c)(iii) (the “Private Placement Shares”). The Buyer shall deliver to Seller the number of Private Placement Shares on the date that the relevant Obligation would otherwise be payable, subject to deferral below
(the “Net Share Settlement Date”). 
  
 (iii) Not
later than the closing time of the Exchange on the Trading Day prior to such Net Share Settlement Date, Seller shall determine the number of Private Placement Shares. Seller shall make this determination by dividing the amount of the relevant
Obligation by the per share Private Placement Value of 

					
	Reference Number CCEGK5-1/	 	Account Number: 3315851	 	 Page
 13

  

 
the Private Placement Shares (and rounding any resulting fraction up to the nearest whole Private Placement Share). The “Private Placement
Value” shall be a per Private Placement Share amount determined by Seller in a commercially reasonable manner and may be based on indicative bids from institutional “accredited investors” (as defined in Rule 501 under the
Securities Act). The parties acknowledge that such value may be discounted to account for, among other things, any transfer restrictions applicable to, or any illiquidity in the market for, any securities constituting all or part of such Private
Placement Shares. 
  
 (iv) The Buyer shall provide Seller and any
institutional accredited investors providing indicative bids with a reasonable opportunity to conduct a due diligence investigation with respect to the Buyer customary in scope for private offerings of equity securities. Seller will be permitted to
defer the Net Share Settlement Date for up to ten Trading Days in order for it and any institutional accredited investors to complete such due diligence and any due diligence with respect to the issuers of any other securities constituting all or
part of the Private Placement Shares. The institutional accredited investors will be asked to provide indicative bids for private purchases of the Private Placement Shares directly from the Buyer based upon the scope and results of such diligence
and the requirements pursuant to Section 14(c)(v) below. 
  
 (v) Delivery of the Shares constituting all or part of the Private Placement Shares to Seller and any resale of such Shares by Seller shall be conducted so as to qualify as private placements exempt from the registration requirements of the
1933 Act. Until such Shares become eligible for resale under Rule 144(k) under the 1933 Act, (i) the certificates evidencing such Shares shall bear customary restrictive legends, (ii) registered transfers of such Shares shall be subject to
appropriate “stop transfer” instructions and (iii) each holder of such Shares shall deliver to the Buyer a customary purchaser’s letter reflecting the restricted nature of such Shares. 
  
 (vi) For the avoidance of doubt, the parties agree that the commissions
incorporated in the definition of “Prepayment Amount” above are commercially reasonable fees for MSCO’s activities in connection with settlement under this Section 14(c). 

					
	Reference Number CCEGK5-1/	 	Account Number: 3315851	 	 Page
 14

  

 15. The parties hereto agree and acknowledge that Seller is a “financial institution” within the
meaning of Section 101(22) of Title 11 of the United States Code (the “Bankruptcy Code”). The parties hereto further agree and acknowledge that this Transaction is either (i) a “securities contract” as such term is
defined in Section 741(7) of the Bankruptcy Code, in which case each payment and delivery made pursuant to this Transaction is a “settlement payment”, as such term is defined in Section 741(8) of the Bankruptcy Code, and that
Seller is entitled to the protections afforded by, among other sections, Sections 362(b)(6), 546(e) and 555 of the Bankruptcy Code, or (ii) a “swap agreement”, as such term is defined in Section 101(53B) of the Bankruptcy Code,
in which case each party is a “swap participant”, as such term is defined in Section 101(53C) of the Bankruptcy Code, and that Seller is entitled to the protections afforded by, among other sections, Sections 362(b)(17), 546(g) and
560 of the Bankruptcy Code. 
  
 16. Subject to any contrary requirement of law,
the right of each party to enforce its rights hereunder in any legal action and the immediately succeeding sentence, each party shall keep strictly confidential and shall cause its employees and agents to keep strictly confidential the terms of this
Agreement and any information of or concerning the other party which it or any of its agents or employees may acquire pursuant to, or in the course of performing its obligations under, any provision of this Agreement. Notwithstanding the foregoing
or anything to the contrary herein, Morgan Stanley and the Issuer agree that (i) the Issuer is not obligated to Morgan Stanley to keep confidential from any and all persons or otherwise limit the use of any element of Morgan Stanley’s
descriptions relating to tax aspects of the transaction contemplated by this Agreement and any part of the structure necessary to understand those tax aspects, (ii) Morgan Stanley does not assert any claim of proprietary ownership in respect of
such descriptions contained herein of the use of any entities, plans or arrangements to give rise to significant U.S. federal income tax benefits for the Issuer and (iii) Buyer may file this agreement as an exhibit to any report filed with or
furnished to the U.S. Securities and Exchange Commission by Buyer. 
  
 17.
Treatment in Bankruptcy; No Setoff; No Collateral. 
  
 (a)
In the event the Buyer becomes the subject of proceedings (“Bankruptcy Proceedings”) under the U.S. Bankruptcy Code or any other applicable bankruptcy or insolvency statute from time to time in effect, any rights or claims of Seller
hereunder in respect of this transaction shall rank for all purposes no higher than, but on a parity with, the rights or claims of holders of Shares, and Seller hereby agrees that its rights and claims hereunder shall be subordinated to those of all
parties with claims or rights against the Buyer (other than common stockholders) to the extent necessary to assure such ranking. Without limiting the generality of the foregoing, after the commencement of Bankruptcy Proceedings, the claims of Seller
hereunder shall for all purposes have rights equivalent to the rights of a holder of a percentage of the Shares equal to the aggregate amount of such claims (the “Claim Amount”) taken as a percentage of the sum of (i) the Claim
Amount and (ii) the aggregate fair market value of all outstanding Shares on the record date for distributions made to the holders of such Shares in the related Bankruptcy Proceedings. Notwithstanding any right it might otherwise have to assert
a higher priority claim in any such Bankruptcy Proceedings, Seller shall be entitled to receive a distribution solely to the extent and only in the form that a holder of such percentage of the Shares would be entitled to receive in such Bankruptcy
Proceedings, and, from and after the commencement of such Bankruptcy Proceedings, Seller expressly waives (i) any other rights or distributions to which it might otherwise be entitled in such Bankruptcy Proceedings in respect of its rights and
claims hereunder and (ii) any rights of setoff it might otherwise be entitled to assert in respect of such rights and claims. 

					
	Reference Number CCEGK5-1/	 	Account Number: 3315851	 	 Page
 15

  

 (b) Notwithstanding any provision of this Agreement or any other agreement between the parties to the
contrary, neither the obligations of the Buyer nor the obligations of Seller hereunder are secured by any collateral, security interest, pledge or lien. 
  
 18. Share Cap. Notwithstanding any other provision of this Agreement to the contrary, in no event shall the Buyer be required to deliver to Seller a number of Shares that
exceeds the Share Cap (as specified in Schedule I), subject to reduction by the number of Shares delivered hereunder by the Buyer on any prior date. 
  
 19. Account Details: 
  

	 Account for Payments to MSCO: 
	 Citibank, NY 

	 	 ABA #021-000-089 

	 	 A/C Morgan Stanley, NY 

	 	 A/C 388-90774 

	 	 For further credit to Customer Account 3315851 

  

	 Account for Payments to Issuer: 
	 To be provided by Issuer 

  
 18. Governing law: The laws of the state of New York. 
  

  
 Please confirm that the foregoing correctly sets forth the
terms of our agreement by executing this Confirmation and returning it to us by facsimile to the number provided on the attached facsimile cover page. 
  
 Confirmed as of the date first written above: 
  

									
	VERISIGN, INC.	 	 	 	MORGAN STANLEY & CO. INCORPORATED
					
	By:	 	  

	 	 	 	By:	 	  

	 	 	 Name:
 Title:
	 	 	 	 	 	 Name:
 Title:

					
	Reference Number CCEGK5-1/	 	Account Number: 3315851	 	 Page
 16

  

 Schedule I 
  
 This Schedule I, dated [November 21, 2005], may be amended and/or superseded from time to time by both mutual agreement of both parties. For the purposes of this
Transaction, the following terms shall have the following values/meanings: 
  
 1.
The Trade Date shall be November 21, 2005 
  
 2. The Discount Percentage
equals 1.35% 
  
 3. The Maximum Forward Price equals USD30.00 
  
 4. The Prepayment Amount equals USD250,000,000 
  
 5. The Scheduled Valuation date shall mean February 23, 2006 
  
 6. The Share Cap shall mean 10,000,000 Shares 
  
  
 AGREED AND
ACKNOWLEDGED (as of the date listed above) 
  
 VERISIGN INC. 
  

			
	
	

	 Name:
 Title

  
  
 MORGAN STANLEY & CO. INC. 

			
	
	

	 Name:
 TitleSettlement and License Agreement made with Linear Technology Corporation

 Exhibit 10.1 
 CONFIDENTIAL INFORMATION OMITTED AND FILED SEPARATELY WITH 
 THE SECURITIES AND EXCHANGE COMMISSION PURSUANT
TO A REQUEST 
 FOR CONFIDENTIAL TREATMENT 
 ASTERISKS (*) DENOTE SUCH OMISSIONS 
 SETTLEMENT AND LICENSE AGREEMENT 
 This Settlement and License Agreement (the “Agreement”) is made and effective the 1st day of October, 2005, by and between Linear Technology
Corporation, with offices at 1630 McCarthy Blvd., Milpitas, CA 95035 (“Linear”) and Monolithic Power Systems, Inc., with offices at 983 University Avenue, Building A, Los Gatos, CA 95032 (“MPS”). Linear and MPS are
collectively referred to as the “Parties.” 
 WHEREAS Linear is the assignee and owner of all rights, title and interest in United
States Patent Nos. 5,481,178 (the “‘178 Patent”) and 6,580,258 (the “‘258 Patent”) (collectively the “Patents-in-Suit”); 
 WHEREAS on or about July 16, 2004, Linear filed a Complaint to commence an investigation by the United States International Trade Commission, which in turn commenced Investigation No. 337-TA-521, entitled
“In the matter of CERTAIN VOLTAGE REGULATOR CIRCUITS, COMPONENTS THEREOF AND PRODUCTS CONTAINING SAME” (the “ITC Proceeding”); 
 WHEREAS MPS filed an answer in the ITC Proceeding alleging that the Patents-in-Suit are invalid, unenforceable and not infringed; 
 WHEREAS Linear and MPS now desire to settle the ITC Proceeding and this dispute between them as hereinafter set forth; 
 The
parties agree as follows: 
 I. DEFINITIONS 
 1.1 As used in this Agreement, “Linear” and “MPS” include and refer to each party’s respective parents, subsidiaries, affiliates and successors. 
 1.2 An “Affiliate” of Linear or MPS, respectively, shall mean any corporation, company or other legal entity, more than fifty percent
(50%) of whose outstanding shares or securities (representing the right to select 

 CONFIDENTIAL INFORMATION OMITTED AND FILED SEPARATELY WITH 
 THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST 
 FOR CONFIDENTIAL TREATMENT 
 ASTERISKS (*) DENOTE SUCH OMISSIONS 
 directors or other managing authority) are, now or hereafter, owned or controlled, directly or indirectly, by Linear or MPS but such corporation, company or other legal
entity shall be deemed an Affiliate only so long as such ownership or control exists. 
 1.3 “Asserted Claims” shall mean the
following patent claims allegedly infringed by MPS: claims 1, 31, 34, 41, 44, 55 and 56 of U.S. Patent No. 5,481,178 and claims 2 and 35 of U.S. Patent No. 6,580,258. 
 1.4 “Claims” shall mean any and all claims, counterclaims, demands, actions and causes of action, and any related damages, liabilities, losses,
payments, obligations, costs and expenses (including, without limitation, attorneys’ fees and costs), of any kind or nature, fixed or contingent, direct or indirect, in law or equity, several or otherwise, known or unknown, suspected or
unsuspected. 
 1.5 “Licensed Patents” shall mean U.S. Patent No. 5,481,178 and U.S. Patent No. 6,580,258, as well as all
continuations, continuations-in-part, divisionals, or reissues or re-examinations thereof, and all foreign patents and patent applications counterpart thereto. 
 1.6 “Licensed Product” shall mean the MP1556 product and the EV0063 evaluation board (to the extent that it includes the MP1556). 
 1.7 “Net Selling Price” shall mean the priced charged by MPS to customers for the sale of the Licensed Product, less (a) returns and
customary trade, quantity, cash discounts and rebates actually allowed and taken either at the time or later; (b) freight and insurance costs, if separately itemized on the invoice paid by the customer; (c) value-added, sales, use, or
similar taxes and customs duties included in the invoice amount; (d) writeoffs of accounts receivable from previous sales of Licensed Product; and (e) other credits or rebates actually allowed and taken either at the time or later.

 1.8 “Sales” or “Sold” shall mean “the passing of title from the seller to the buyer for a price (Section
2401)” as set forth at California U.C.C. Section 2106(1), from a person within the definition of MPS to a person not within the definition of MPS. 
  

 -2- 

 CONFIDENTIAL INFORMATION OMITTED AND FILED SEPARATELY WITH 
 THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST 
 FOR CONFIDENTIAL TREATMENT 
 ASTERISKS (*) DENOTE SUCH OMISSIONS 
 II. SETTLEMENT AND RELEASE 
 2.1 The Parties
agree to move for termination of the ITC investigation within one day of execution of this Agreement, and to submit a Consent Order and Consent Order Stipulation to the ITC in the form attached hereto as Exhibit A, together with a Joint Motion
for Termination of the Proceeding, and a Joint Motion to Suspend the Hearing pending the termination motion, in the form attached hereto as Exhibit B. 
 2.2 In consideration for MPS’s agreement to the Consent Order and other provisions set forth herein, Linear releases MPS from any and all Claims and liability for any alleged past infringement of the Licensed
Patents. Linear further agrees that it will not assert the Licensed Patents against MPS or its direct or indirect customers, agents, suppliers or distributors for use, manufacture, importation, offer for sale, sale or other distribution of Licensed
Products that were sold by or on behalf of MPS prior to the Effective Date of this Agreement. 
 2.3 Linear and MPS irrevocably and
perpetually release and waive worldwide any and all Claims that they would have been compelled to bring in the ITC Proceeding or any related litigation against each other. Linear and MPS each represent and warrant that, on the date of its execution
of this Agreement, it is unaware of any other Claims related to the Licensed Patents which it might bring or assert against each other. Each party expressly waives any rights or benefits available to it in any capacity under the provisions of
Section 1542 of the California Civil Code and of any similar statute, law, regulation, principle of judicial interpretation or other rule (of California or any other jurisdiction.). Such Section 1542 provides: 
 A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH
IF KNOWN BY HIM MUST HAVE MATERIALLY AFFECTED HIS SETTLEMENT WITH THE DEBTOR. 
 2.4 MPS shall be responsible for and pay its own costs,
expenses and attorneys’ fees in connection with the ITC Proceeding and settlement 
  

 -3- 

 CONFIDENTIAL INFORMATION OMITTED AND FILED SEPARATELY WITH 
 THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST 
 FOR CONFIDENTIAL TREATMENT 
 ASTERISKS (*) DENOTE SUCH OMISSIONS 
 thereof. Linear shall be responsible for and pay its own costs, expenses and attorneys’ fees in connection with the ITC Proceeding and settlement thereof.

 2.5 MPS agrees that, in any proceeding to enforce the Consent Order or this Agreement, MPS will not challenge or otherwise contest the
validity of the Patents-in-Suit. 
 III. LICENSE 
 3.1 Linear hereby grants to MPS a non-exclusive, worldwide license under the Licensed Patents to use, make, have made, import, offer to sell, and sell or otherwise transfer Licensed Product. MPS’ license to the
Licensed Patents does not include the right to grant sublicenses, and MPS’ “have made” rights do not include any right to act as a sales agent, commission agent, broker, factor distributor or reseller of Licensed Products made by
third parties. 
 3.2 The term of this license shall be from the Effective Date through and including March 31, 2006 (the
“Expiration Date”). This license shall terminate as of the Expiration Date, and MPS agrees that, by that date, it will discontinue any and all sales of the Licensed Product. Linear agrees that it will not assert the Licensed Patents
against MPS or its direct or indirect customers, agents, suppliers, or distributors for use, manufacture, importation, offer for sale, sale or other distribution of Licensed Product that was sold by or on behalf of MPS prior to the Expiration Date.

 3.3 MPS agrees that it has not made and will not make any sales of its MP1557-1559 products anywhere in the world. MPS further agrees
that, except with respect to the Licensed Product, it has not made and will not make any sales of any other products in which the ZX circuitry identified by counsel for Linear in the ITC Proceeding is connected so as to allow such products to enter
into what Linear referred to as “sleep mode,” “reverse polarity protection”, or otherwise practice the Asserted Claims anywhere in the world. For avoidance of doubt, Linear agrees that the MPS products, such as the MP2104, that
have the accused ZX circuitry disabled as set forth in the ITC proceeding, do not infringe the Licensed Patents and that MPS may continue to make, have made, use, sell and offer to sell such products. 
  

 -4- 

 CONFIDENTIAL INFORMATION OMITTED AND FILED SEPARATELY WITH 
 THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST 
 FOR CONFIDENTIAL TREATMENT 
 ASTERISKS (*) DENOTE SUCH OMISSIONS 
 IV. ***APPROXIMATELY 1 LINE OMITTED*** 
 4.1
In consideration of the license and rights granted hereunder, ***APPROXIMATELY 7 LINES OMITTED*** 
 4.2 ***APPROXIMATELY 5 LINES OMITTED***

 4.3 MPS shall keep full, complete and accurate books and records containing all particulars which may be reasonably necessary for
determining the royalty payable to Linear. Such books of account shall be kept at MPS’s principal place of business. Linear may request at its option that such books of account shall be made available for inspection, upon reasonable notice and
subject to appropriate non-disclosure agreements. Such inspection shall be by an independent auditor agreed upon by Linear and MPS. Linear may elect to terminate any audit prior to its completion. If the auditor confirms that the royalty paid by MPS
during the audited period was at least ninety percent (90%) of the amount due, then Linear shall bear the expense of the auditor. If the auditor determines that during the audited period MPS paid less than ninety percent (90%) of the
royalty due, then MPS shall bear the expense of the auditor. In either event, all persons conducting the audit shall retain as confidential all MPS financial and other information, and may disclose to Linear only the total revenue base by quarter of
all Licensed Product. 
 V. CONFIDENTIALITY 
 5.1 Except as may otherwise be required by law, including public financial filing requirements, each party shall keep the financial terms of this Agreement confidential and shall not disclose such terms or provisions
without first obtaining the written consent of the other party. The confidentiality obligations hereunder do not apply to the existence of this Agreement, but do apply to the terms and conditions hereof. The parties mutually agree to redact such
terms and conditions from any public version of this Agreement filed with the ITC that contain information of commercial value. In addition, other than as may be required by corporate disclosure laws, neither party shall issue a press release
concerning this Agreement, the Consent Order, or any other aspect of the ITC Proceedings. 
  

 -5- 

 CONFIDENTIAL INFORMATION OMITTED AND FILED SEPARATELY WITH 
 THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST 
 FOR CONFIDENTIAL TREATMENT 
 ASTERISKS (*) DENOTE SUCH OMISSIONS 
 VI. VENUE AND GOVERNING LAW 
 6.1 This
Agreement is to be construed in accordance with and governed by the laws of the State of California without giving effect to any choice of law rule that would cause the application of the laws of any jurisdiction other than the laws of the State of
California to the rights and obligations of the parties. The parties agree that any action arising out of or otherwise relating to this Agreement, including, without limitation, any action relating to the breach, interpretation or enforceability of
this Agreement, shall be brought in the United States District Court for the District of Delaware or, if such court lacks jurisdiction, the courts of the State of Delaware. Each party hereby consents to the personal jurisdiction of, and waives any
objection to venue in, such court. Notwithstanding the provisions of this section, Linear may also bring a proceeding to enforce the Consent Order in the ITC. In any proceeding brought pursuant to this section 6.1, the prevailing party shall be
entitled to recover its attorneys’ fees. ***APPROXIMATELY 3 LINES OMITTED*** The liquidated damages provision shall not affect remedies available to Linear in any district court action for infringement of the Patents-in-Suit. ***APPROXIMATELY 6
LINES OMITTED*** 
 VII. RETURN OF DOCUMENTS 
 7.1 Not later than sixty (60) days after the Effective Date, all copies of documents containing confidential or proprietary information of a party produced in the ITC Proceeding by such party to the other party
or otherwise obtained in the course of the litigation shall be destroyed or returned to counsel for the producing party, with the exception of an archival copy of pleadings, correspondence, work product, interrogatory responses, depositions,
deposition exhibits, court exhibits and other documents included in submissions to the ITC, which may be retained by outside counsel for each party, subject, however, to compliance with any protective orders or other orders of the ITC. Each party
and its outside counsel shall certify compliance with the obligations of this Section 7.1. 
  

 -6- 

 CONFIDENTIAL INFORMATION OMITTED AND FILED SEPARATELY WITH 
 THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST 
 FOR CONFIDENTIAL TREATMENT 
 ASTERISKS (*) DENOTE SUCH OMISSIONS 
 VIII. MISCELLANEOUS 
 8.1 MPS and Linear each
represents and covenants to the other that it is duly existing; that it has the full power and authority to enter into this Settlement and License Agreement; that it has not previously assigned to any person any claim against the other; that this
Agreement does not and will not interfere with any other agreement to which it is a party and that it will not enter into any agreement the execution and/or performance of which would violate or interfere with this Agreement. 
 8.2 This Agreement shall be non-assignable except in connection with an acquisition of MPS, all or substantially all of MPS’ assets, or all or
substantially all of the MPS business that includes the Licensed Product. The license rights pursuant to any assignment shall be limited to the acquired assets or business of MPS, and shall require the acquiring party to undertake MPS’ royalty
and other obligations under the Agreement, provided that the acquiring party may elect to apply its license agreement and the terms of its license to MPS in lieu of this Agreement following the acquisition, if the acquiring party’s license
permits such an election. 
 8.3 If one or more of the provisions of this Agreement are ruled wholly or partly invalid or unenforceable by
the court, arbitrator or other government body of competent jurisdiction, then the validity and enforceability of all of the other provisions of this Agreement will be unaffected; and the provisions held wholly or partly invalid or unenforceable
will be deemed amended, and the court, arbitrator or other government body shall reform the offending provision or provisions to the minimum extent necessary to render such provision or provisions valid and enforceable and, as so reformed, this
Agreement shall be fully enforced. 
 8.4 Linear and MPS each represents that it has had the opportunity to be represented by counsel of its
own choice in negotiating this Agreement. This Agreement shall therefore be deemed to have been negotiated and prepared at the joint request, direction and instruction of Linear and MPS, at arms length, with the advice and participation of counsel,
and will be interpreted in accordance with its terms without favor to either Linear or MPS. 
 8.5 Linear and MPS agree that neither this
Settlement and License Agreement nor any act under it constitutes or shall be construed to constitute an admission of liability or fault of any kind by MPS, which liability or fault of MPS expressly denies. 
  

 -7- 

 CONFIDENTIAL INFORMATION OMITTED AND FILED SEPARATELY WITH 
 THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST 
 FOR CONFIDENTIAL TREATMENT 
 ASTERISKS (*) DENOTE SUCH OMISSIONS 
 8.6 Linear and MPS agree that they will each sign such further documents and take such further acts as may be necessary to carry out the intent of this
Agreement. 
 8.7 This Agreement may be signed in counterparts and shall be effective only when signed by Linear and MPS. 
 8.8 Any notice, demand, request, waiver or other communication required or permitted to be given hereunder shall be in writing and shall be effective
(a) upon hand delivery, by telecopy or facsimile at the address or number designated below (if delivered on a Business Day during normal business hours where such notice is to be received), or the first Business Day following such delivery (if
delivered other than a Business Day during normal business hours where such notice is to be received), or (b) on the second Business Day following the date of mailing by express courier service, full prepaid, addressed to such address, or upon
actual receipt of such mailing, whichever shall first occur. The addresses for such communications shall be: 
  

			
	If to Linear:	  	 Linear Technology Corporation
 1630 McCarthy
Blvd.
 Milpitas, CA 95035
 ATTN: CEO/CFO
 Fax: 408-434-0507

		
		  	 with a mandatory copy to:
  
 McDermott Will & Emery LLP
 600 13th Street, N.W.
 Washington, DC 20005
 ATTN: Stephen Becker
 Fax: 202-756-8087

  

 -8- 

			
		
	If to MPS:	  	 Monolithic Power Systems, Inc.
 983 University
Avenue
 Building A
 Los Gatos, California 92618
 ATTN: CEO
 Fax: (408) 357-6601

		
		  	 with a mandatory copy to:
  
 Latham & Watkins
 633 West Fifth Street
 Suite 4000
 Los Angeles, CA 90071
 ATTN: Robert Steinberg
 Fax: (213) 891-8763

 CONFIDENTIAL INFORMATION OMITTED AND FILED SEPARATELY WITH 
 THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST 
 FOR CONFIDENTIAL TREATMENT 
 ASTERISKS (*) DENOTE SUCH OMISSIONS 
 Either party may change its address by the notice given to the other party in the manner set forth. 
 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed by their respective duly authorized officers as of the Effective Date. 
  

							
	Date: September 29, 2005	 		 	Linear Technology Corporation
				
		 		 	By:	 	 /S/ LOTHAR MAIER

		 		 	Title:	 	CEO
			
	Date: September 29, 2005	 		 	Monolithic Power Systems, Inc.
				
		 		 	By:	 	 /S/ MICHAEL R. HSING

		 		 	Title:	 	CEO & President

  

 -9-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00099-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00099-of-00352.parquet"}]]